Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds

被引:18
|
作者
Ssemanda, Elizabeth N. [1 ]
Levens, Joshua [1 ]
Mkocha, Harran [2 ]
Munoz, Beatriz [1 ]
West, Sheila K. [1 ]
机构
[1] Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA
[2] Kongwa Trachoma Project, Kongwa, Tanzania
来源
PLOS NEGLECTED TROPICAL DISEASES | 2012年 / 6卷 / 03期
关键词
D O I
10.1371/journal.pntd.0001576
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Backgroud: Persistent non-participation of children in mass drug administration (MDAs) for trachoma may reduce program impact. Risk factors that identify families where participation is a problem or program characteristics that foster non-participation are poorly understood. We examined risk factors for households with at least one child who did not participate in two MDAs compared to households where all children participated in both MDAs. Methods/Principal Findings: We conducted a case control study in 28 Tanzanian communities. Cases included all 152 households with at least one child who did not participate in the 2008 and 2009 MDAs with azithromycin. Controls consisted of a random sample of 460 households where all children participated in both MDAs. A questionnaire was asked of all families. Random-intercept logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs), control for clustering, and adjust for community size. In total, 140 case households and 452 control households were included in the analyses. Compared to controls, guardians in case households had higher odds of reporting excellent health (OR 4.12 (CI 95% 1.57-10.86)), reporting a burden due to family health (OR 3.15 (95% CI 1.35-7.35)), reduced ability to rely on others for assistance (OR 1.66 (95% CI 1.01-2.75)), being in a two (versus five) days distribution program (OR 3.31 (95% CI 1.68-6.50)) and living in a community with <2 community treatment assistants (CTAs)/1000 residents (OR 2.07 (95% CI 1.04-4.12). Furthermore, case households were more likely to have more children, younger guardians, unfamiliarity with CTAs, and CTAs with more travel time to their assigned households (p-values<0.05). Conclusions/Significance: Compared to full participation households, households with persistent non-participation had a higher burden of familial responsibility and seemed less connected in the community. Additional distribution days and lessening CTAs' travel time to their furthest assigned households may prevent non-participation.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial
    Christian Kositz
    Hristina Vasileva
    Nuredin Mohammed
    Jane Achan
    Edgard Diniba Dabira
    Umberto D’Alessandro
    John Bradley
    Michael Marks
    Malaria Journal, 23
  • [22] Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial
    Kositz, Christian
    Vasileva, Hristina
    Mohammed, Nuredin
    Achan, Jane
    Dabira, Edgard Diniba
    D'Alessandro, Umberto
    Bradley, John
    Marks, Michael
    MALARIA JOURNAL, 2024, 23 (01)
  • [23] Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
    Benjamin F. R. Dickson
    Patricia M. Graves
    Ni Ni Aye
    Thet Wai Nwe
    Tint Wai
    San San Win
    Myint Shwe
    Janet Douglass
    Peter Wood
    Kinley Wangdi
    William J. McBride
    Parasites & Vectors, 14
  • [24] Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children
    Whitty, CJM
    Glasgow, KW
    Sadiq, ST
    Mabey, DC
    Bailey, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (11) : 955 - 958
  • [25] A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children
    Dawson, CR
    Schachter, J
    Sallam, S
    Sheta, A
    Rubinstein, RA
    Washton, H
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 363 - 368
  • [26] Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
    Dickson, Benjamin F. R.
    Graves, Patricia M.
    Aye, Ni Ni
    Nwe, Thet Wai
    Wai, Tint
    Win, San San
    Shwe, Myint
    Douglass, Janet
    Wood, Peter
    Wangdi, Kinley
    McBride, William J.
    PARASITES & VECTORS, 2021, 14 (01)
  • [27] Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma
    Fraser-Hurt, N
    Bailey, RL
    Cousens, S
    Mabey, D
    Faal, H
    Mabey, DCW
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2001, 79 (07) : 632 - 640
  • [28] Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children
    Frick, KD
    Lietman, TM
    Holm, SO
    Jha, HC
    Chaudhary, JSP
    Bhatta, RC
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2001, 79 (03) : 201 - 207
  • [29] Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
    West, Sheila K.
    Munoz, Beatriz
    Mkocha, Harran
    Gaydos, Charlotte A.
    Quinn, Thomas C.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (02): : 268 - 273
  • [30] Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania
    Frick, KD
    Lynch, M
    West, S
    Munoz, B
    Mkocha, HA
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2003, 81 (02) : 101 - 107